Background: The purposes of this article are (1) to report on the overall desirability of the DEKA Arm by prototype and by level of prosthesis, (2) to report on user-perceived benefits of the DEKA Arm as compared to their current prostheses, and (3) to summarize user concerns about taking the device home.
Study Design: Qualitative content analysis of data from a multiple case study design.
Methods: This study utilized data from 24 upper-limb amputees fit with a Gen 2 DEKA Arm and 13 fit with a Gen 3 DEKA Arm. Surveys were administered after fitting the DEKA Arm and at the end of training. Subjects recorded audiotaped comments about their experiences. All study sessions were videotaped.
Results: In all, 79% of Gen 2 and 85% of Gen 3 users indicated that either they wanted to receive or might want to receive a DEKA Arm. In total, 95% of Gen 2 and 91% of Gen 3 prior prosthesis users reported that they were able to perform new activities that they were unable to perform with their own device.
Conclusions: A large majority of subjects wanted a DEKA Arm, although desirability varied by amputation level.
Clinical Relevance: The majority of amputees in this study expressed a desire to receive the DEKA Arm, a device which provides multiple powered degrees of freedom and is operated predominantly by foot controls. The majority reported functional advantages of the DEKA Arm over their existing prostheses.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0309364613506914 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Acceptability of a Portable Exercise Bike in Older Adults With Cardiovascular Diseases.
West J Nurs Res
November 2024
College of Nursing, Michigan State University, East Lansing, MI, USA.
Background: Ways to help older adults overcome barriers to performing regular exercise is a challenge to nurses.
Objective: The study evaluated the acceptability of a portable exercise bike for arm/foot pedaling among older patients with cardiovascular diseases (CVDs).
Methods: Participants reported their physical activity levels using the International Physical Activity Questionnaire (short form) and thereafter performed two 6-minute-long arm/foot pedal biking sessions using a portable exercise bike.
Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly.
Cancer Res Commun
August 2024
National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.
Unlabelled: Kaposi sarcoma is a rare angioproliferative disease associated with human herpes virus-8 (HHV-8) infection. Kaposi sarcoma is frequent and aggressive in HIV-infected people, whereas the classic form (CKS) generally has an indolent course. Notably, all conventional therapies against Kaposi sarcoma have only temporary efficacy.
View Article and Find Full Text PDFCabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.
Nat Med
September 2024
Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Supplementation with CBM588, a bifidogenic live bacterial product, has been associated with improved clinical outcomes in persons with metastatic renal cell carcinoma (mRCC) receiving nivolumab and ipilimumab. However, its effect on those receiving tyrosine kinase inhibitor-based combinations is unknown. In this open-label, randomized, investigator-initiated, phase 1 study, 30 participants with locally advanced or mRCC with histological confirmation of clear cell, papillary or sarcomatoid component were randomized in a 2:1 fashion to receive cabozantinib (an inhibitor of vascular endothelial growth factor receptor, MET and AXL) and nivolumab (anti-programmed cell death protein 1) with or without CBM588 as first-line treatment.
View Article and Find Full Text PDFSociety for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease.
J Immunother Cancer
April 2024
Center for Biotherapies In Situ (BIOTHERIS), INSERM CIC1428, Department for Therapeutic Innovation and Early Phase Trials (DITEP), Gustave Roussy Cancer Center, University of Paris Saclay, Villejuif, France.
Article Synopsis
- Scientists believe that delivering special medicines directly into tumors could help fight cancer better.
- An expert group worked together to figure out how to create better tests for these new treatments, including which patients to help.
- They discussed different ideas on how to design these tests, so they can learn the most about how well the new therapies work for different types of cancer.
Association between Physical Fitness and Perceived Well-Being in Functionally Independent Community Dwelling Elderly of North-Eastern India.
Acta Med Litu
January 2023
Department of General Medicine, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong-793018, India.
Background: Regular physical activity helps in independent living, prevention of chronic health problems and quality of life in the elderly. The aim of the study is to determinewhether physical fitness is associated with multiple dimensions of well-being in the community dwelling elderly.
Materials And Methods: A community-based cross-sectional study was undertaken to assess the physical fitness and perceived wellness in 400 elderly (≥65 years) subjects.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!